{
  "disease_name": "Melanoma",
  "synonyms": [
    "Malignant melanoma"
  ],
  "summary": "Melanoma is a serious type of skin cancer that develops from melanocytes. It typically occurs on the skin but can rarely affect the mouth, intestines, or eyes. Early signs often involve changes in a mole's size, shape, color, or feel, with a common mnemonic being ABCDE (Asymmetry, Border, Color, Diameter, Evolving).",
  "causes": [
    "DNA damage from UV light exposure",
    "Genetic mutations",
    "Mutations in BRAF genes (V600E, V600K)",
    "Mutations in RAS genes (NRAS, HRAS, KRAS)",
    "Loss-of-function mutations in tumor suppressor genes (NF1, TP53, CDKN2A)",
    "Kinase fusions (BRAF, RAF1, ALK, RET, ROS1, NTRK1, NTRK3, MET)",
    "Human endogenous retroviruses (HERV-K) activity"
  ],
  "risk_factors": [
    "Ultraviolet light (UV) exposure (sun or tanning devices)",
    "Low levels of skin pigment melanin",
    "Many moles",
    "Family history of melanoma",
    "Poor immune function",
    "Xeroderma pigmentosum",
    "Dysplastic nevus syndrome (familial atypical multiple mole melanoma - FAMMM)",
    "Fair skin",
    "Red hair",
    "Multiple atypical nevi or dysplastic nevi",
    "Giant congenital melanocytic nevi",
    "Older age",
    "Male sex (in the US)",
    "Frequent severe sunburns",
    "Living close to the equator",
    "Occupational exposure to UV radiation (e.g., working in airplanes)",
    "Early age of sun exposure",
    "High socioeconomic conditions (professional/administrative workers)"
  ],
  "symptoms": [
    "Change in size, shape, color, or feel of a mole",
    "Black or black-blue area in a mole",
    "New mole",
    "Ragged, blurred, or irregular border of a mole",
    "Uneven color of a mole (shades of black, brown, tan)",
    "Change in mole size (usually increase)",
    "Mole evolving over time",
    "Itchiness of a mole",
    "Skin breakdown on a mole",
    "New lump on the skin (nodular melanoma)",
    "Elevated above the skin surface (nodular melanoma)",
    "Firm to the touch (nodular melanoma)",
    "Growing (nodular melanoma)",
    "Loss of appetite (metastatic melanoma)",
    "Nausea (metastatic melanoma)",
    "Vomiting (metastatic melanoma)",
    "Fatigue (metastatic melanoma)",
    "Ulceration of a mole",
    "Bleeding from a mole"
  ],
  "diagnosis": [
    "Visual inspection of skin lesion",
    "Dermoscopy",
    "Reflectance confocal microscopy",
    "Total body photography",
    "Skin biopsy (excisional, incisional, punch)",
    "Histological analysis",
    "Breslow scoring",
    "Clark level assessment",
    "Imaging (CT scans, MRIs, PET/CTs, ultrasound) for metastasis",
    "Sentinel lymph node biopsy",
    "LDH levels (may be elevated in metastatic melanoma)",
    "S-100 protein marker",
    "HMB-45 antibody"
  ],
  "treatments": [
    "Surgery (excision, wide local excision, Mohs surgery)",
    "Chemotherapy (dacarbazine, temozolomide, fotemustine)",
    "Radiation therapy",
    "Biologic therapy",
    "Targeted therapy (BRAF inhibitors, MEK inhibitors, C-Kit inhibitors, NRAS inhibitors)",
    "Immunotherapy (cytokines like IFN-a and IL-2, immune checkpoint inhibitors like ipilimumab, nivolumab, pembrolizumab, anti-PD-1 antibodies, anti-CTLA-4 antibodies)",
    "Adoptive cell transfer (ACT) using tumor-infiltrating lymphocytes (TILs)",
    "Adoptive transfer of genetically altered autologous lymphocytes",
    "Cancer vaccines",
    "Isolated limb infusion (ILI)",
    "Imiquimod (topical cream)",
    "Talimogene laherparepvec (T-VEC)",
    "Antiretrovirals (lamivudine, doravirine, cabotegravir)",
    "Observation (for early stage or after resection)",
    "Supportive and palliative care"
  ],
  "related_genes": [
    "BRAF",
    "RAS (NRAS, HRAS, KRAS)",
    "NF1",
    "TP53",
    "CDKN2A",
    "MC1R",
    "RAF1",
    "ALK",
    "RET",
    "ROS1",
    "NTRK1",
    "NTRK3",
    "MET",
    "MDM2 SNP309",
    "IGF1R",
    "MCM6",
    "TIMELESS",
    "WIPI1"
  ],
  "subtypes": [
    "Nodular melanoma",
    "Amelanotic melanoma",
    "Acral melanoma",
    "Mucosal melanoma",
    "Desmoplastic melanoma",
    "Melanoma with small nevus-like cells",
    "Melanoma with features of a Spitz nevus",
    "Uveal melanoma",
    "Vaginal melanoma",
    "Polypoid melanoma",
    "Melanoma in situ",
    "Lentigo maligna melanoma",
    "Superficial spreading melanoma",
    "Acral lentiginous melanoma",
    "BRAF mutant subtype",
    "RAS mutant subtype",
    "NF1 mutant subtype",
    "Triple wild-type subtype"
  ]
}